Previous Close | 198.15 |
Open | 196.07 |
Bid | 194.26 x 800 |
Ask | 205.18 x 800 |
Day's Range | 192.40 - 202.71 |
52 Week Range | 181.22 - 262.00 |
Volume | |
Avg. Volume | 457,791 |
Market Cap | 10.235B |
Beta (5Y Monthly) | 1.33 |
PE Ratio (TTM) | 22.28 |
EPS (TTM) | 8.96 |
Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 242.31 |
Subscribe to Yahoo Finance Plus to view Fair Value for CRL
Charles River Laboratories International Inc (NYSE:CRL) recently experienced a daily loss of -5.21%, and a 3-month loss of -0.43%. This article aims to answer that question through a detailed valuation analysis of Charles River Laboratories International (NYSE:CRL). Established in 1947, Charles River Laboratories International Inc (NYSE:CRL) is a leading provider of drug discovery and development services.
WILMINGTON, Mass., September 20, 2023--Charles River Laboratories to Host Investor Day on September 21, 2023
Exploring the robust financial stance and growth prospects of Charles River Laboratories International Inc (CRL)